Medpace raises 2026 EPS guidance range
jurgenfr
- Medpace Holdings' (MEDP) 2026 diluted GAAP EPS guidance range of $17.97 to $18.32 is above the consensus of $17.59. It was previously $17.25 to $17.95.
- The contract research organization's full-year revenue outlook is $2.835B to $2.855B, putting the midpoint below the consensus of $2.85B.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.